Shares of insurers and pharmacy benefit manager (PBM) companies such as Centene, Elevance Health, Humana and CVS Health are ...

CVS Health's poor 2024 performance could be turning around in 2025 with a new CEO and potential rebound, despite challenges.

Former Rep. Larry Bucshon (R-Ind.) said in an interview Thursday that he expects pieces of health care legislation that were ...

Erin Wright, an analyst from Morgan Stanley, maintained the Buy rating on UnitedHealth (UNH – Research Report). The associated price target ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story UnitedHealth CEO blames drug companies ...

FDA Commissioner Robert Califf is closing the book on his second stint leading the agency that regulates products accounting ...

UnitedHealth posted a better-than-expected profit in the final quarter of 2024, but revenue fell short as challenges like ...

International: Shares of the health care giant slid Thursday after it released its first financial report since the brazen ...

A U.S. appeals court temporarily blocked a generic version of Novartis' Entresto, and new price limits challenge pharma as ...

The National Association of Chain Drug Stores (NACDS) today announced "Four Wins to Make America Healthy Again" – immediate actions the Trump Administration can take to improve the affordability and ...

Analyst Joanna Gajuk of Bank of America Securities maintained a Buy rating on UnitedHealth (UNH – Research Report), reducing the price target ...

The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...